Baiyunshan announcement, Baiyunshan Pharmaceutical General Factory of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. recently received the approval notice of Drug Supplementary Application issued by the State Drug Administration. Cefradine capsule (0.125g, 0.25g) has passed the consistency evaluation of generic drug quality and efficacy.
白云山：分公司药品通过仿制药一致性评价
Baiyunshan: the consistency evaluation of drugs passed by generic drugs in the branch company
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.